4dmedical Limited Stock Key Fundamental Indicators
| FDMDF Stock | USD 2.19 0.03 1.35% |
As of the 9th of February, 4DMedical shows the Risk Adjusted Performance of 0.1296, mean deviation of 4.66, and Coefficient Of Variation of 670.14. 4DMedical Limited technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm 4DMedical Limited maximum drawdown, and the relationship between the information ratio and downside variance to decide if 4DMedical Limited is priced fairly, providing market reflects its regular price of 2.19 per share. Please also double-check 4DMedical Limited total risk alpha, which is currently at 0.5864 to validate the company can sustain itself at some future date.
4DMedical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing 4DMedical's valuation are provided below:4DMedical Limited does not at this time have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. 4DMedical |
4DMedical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to 4DMedical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of 4DMedical.
| 11/11/2025 |
| 02/09/2026 |
If you would invest 0.00 in 4DMedical on November 11, 2025 and sell it all today you would earn a total of 0.00 from holding 4DMedical Limited or generate 0.0% return on investment in 4DMedical over 90 days. 4DMedical is related to or competes with PolyNovo, CellaVision, Xvivo Perfusion, Sosei Group, Beijing Tong, GenSight Biologics, and Allergy Therapeutics. 4DMedical Limited operates as a medical technology company in Australia and the United States More
4DMedical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure 4DMedical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess 4DMedical Limited upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 9.13 | |||
| Information Ratio | 0.1417 | |||
| Maximum Drawdown | 99.01 | |||
| Value At Risk | (6.87) | |||
| Potential Upside | 14.91 |
4DMedical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for 4DMedical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as 4DMedical's standard deviation. In reality, there are many statistical measures that can use 4DMedical historical prices to predict the future 4DMedical's volatility.| Risk Adjusted Performance | 0.1296 | |||
| Jensen Alpha | 1.59 | |||
| Total Risk Alpha | 0.5864 | |||
| Sortino Ratio | 0.1837 | |||
| Treynor Ratio | 0.8581 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of 4DMedical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
4DMedical February 9, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1296 | |||
| Market Risk Adjusted Performance | 0.8681 | |||
| Mean Deviation | 4.66 | |||
| Semi Deviation | 2.61 | |||
| Downside Deviation | 9.13 | |||
| Coefficient Of Variation | 670.14 | |||
| Standard Deviation | 11.85 | |||
| Variance | 140.31 | |||
| Information Ratio | 0.1417 | |||
| Jensen Alpha | 1.59 | |||
| Total Risk Alpha | 0.5864 | |||
| Sortino Ratio | 0.1837 | |||
| Treynor Ratio | 0.8581 | |||
| Maximum Drawdown | 99.01 | |||
| Value At Risk | (6.87) | |||
| Potential Upside | 14.91 | |||
| Downside Variance | 83.44 | |||
| Semi Variance | 6.83 | |||
| Expected Short fall | (23.74) | |||
| Skewness | 5.7 | |||
| Kurtosis | 38.77 |
4DMedical Limited Backtested Returns
4DMedical is abnormally volatile given 3 months investment horizon. 4DMedical Limited secures Sharpe Ratio (or Efficiency) of 0.15, which signifies that the company had a 0.15 % return per unit of price deviation over the last 3 months. We were able to break down twenty-six different technical indicators, which can help you to evaluate if expected returns of 1.82% are justified by taking the suggested risk. Use 4DMedical Risk Adjusted Performance of 0.1296, coefficient of variation of 670.14, and Mean Deviation of 4.66 to evaluate company specific risk that cannot be diversified away. 4DMedical holds a performance score of 12 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 2.05, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, 4DMedical will likely underperform. Use 4DMedical downside variance, day median price, and the relationship between the maximum drawdown and skewness , to analyze future returns on 4DMedical.
Auto-correlation | -0.44 |
Modest reverse predictability
4DMedical Limited has modest reverse predictability. Overlapping area represents the amount of predictability between 4DMedical time series from 11th of November 2025 to 26th of December 2025 and 26th of December 2025 to 9th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of 4DMedical Limited price movement. The serial correlation of -0.44 indicates that just about 44.0% of current 4DMedical price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.44 | |
| Spearman Rank Test | -0.01 | |
| Residual Average | 0.0 | |
| Price Variance | 0.09 |
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, 4DMedical Limited has an Operating Margin of -34.8578%. This indicator is about the same for the Healthcare average (which is currently at -35.08) sector and 11.33% lower than that of the Medical Devices industry. The operating margin for all United States stocks is notably higher than that of the company.
4DMedical Limited Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining 4DMedical's current stock value. Our valuation model uses many indicators to compare 4DMedical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across 4DMedical competition to find correlations between indicators driving 4DMedical's intrinsic value. More Info.4DMedical Limited is rated below average in return on equity category among its peers. It is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the 4DMedical's earnings, one of the primary drivers of an investment's value.4DMedical Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses 4DMedical's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of 4DMedical could also be used in its relative valuation, which is a method of valuing 4DMedical by comparing valuation metrics of similar companies.4DMedical is currently under evaluation in operating margin category among its peers.
4DMedical Fundamentals
| Return On Equity | -0.34 | |||
| Return On Asset | -0.28 | |||
| Operating Margin | (34.86) % | |||
| Current Valuation | 55.4 M | |||
| Shares Outstanding | 294.49 M | |||
| Shares Owned By Insiders | 35.16 % | |||
| Shares Owned By Institutions | 10.35 % | |||
| Price To Book | 2.69 X | |||
| Price To Sales | 102.71 X | |||
| Revenue | 1.05 M | |||
| Gross Profit | 280.62 K | |||
| EBITDA | (35.25 M) | |||
| Net Income | (24.59 M) | |||
| Cash And Equivalents | 60.19 M | |||
| Cash Per Share | 0.20 X | |||
| Total Debt | 1.3 M | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 12.93 X | |||
| Book Value Per Share | 0.20 X | |||
| Cash Flow From Operations | (25.27 M) | |||
| Earnings Per Share | (0.05) X | |||
| Number Of Employees | 133 | |||
| Beta | 0.21 | |||
| Market Capitalization | 86.14 M | |||
| Total Asset | 74.31 M | |||
| Z Score | 39.6 | |||
| Net Asset | 74.31 M |
About 4DMedical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze 4DMedical Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 4DMedical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 4DMedical Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.4DMedical Limited operates as a medical technology company in Australia and the United States. The company was incorporated in 2012 and is based in Carlton, Australia. 4Dmedical operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 95 people.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in 4DMedical Pink Sheet
4DMedical financial ratios help investors to determine whether 4DMedical Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 4DMedical with respect to the benefits of owning 4DMedical security.